HIV Prevention On-Demand

 

HIV PRevention 2016 

HIV Prevention Button 

About the Program:

Program Overview:

While there has been significant progress in the prevention of new HIV infections, transmission of HIV continues. Clearly, more needs to be done to reduce the rate of new infections through such approaches as increased HIV testing, behavioral interventions and the use of pre-exposure prophylaxis (PrEP). However, many clinicians are not fully equipped to guide their patients through the complex issues associated with HIV prevention. This situation results in patients not receiving optimal preventative care as described in national guidelines and to an increased number of people becoming infected with HIV who might otherwise not be infected.

This educational program has been designed to address these challenges. This program will include case studies to educate clinicians who work with various patient populations - especially high-risk patients - about the theoretical framework, latest findings and ongoing research in this field, and to review the professional guidelines in this area. In addition, this program will educate clinicians with strategies to provide improved prevention services to patients, which is expected to help reduce the number of new HIV infections.

Back to Top

Target Audience:

This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.

Back to Top

Learning Objectives:

Upon completion of the program, participants should be able to:

  • Recognize in clinical practice risk factors that contribute to the continued spread of HIV, especially in high-risk populations
  • Apply in clinical practice strategies to reduce the risk of new infections with HIV in various populations
  • Explain the rationale behind various behavioral and medical prevention strategies, including how research findings on these approaches can be applied to clinical practice
  • Clinically apply findings and ongoing research on the use of vaccines, pre-exposure prophylaxis, post-exposure prophylaxis, and other prevention strategies in various populations
  • Discuss with patients methods to minimize the spread of HIV infection

Release Date: June 10, 2016

Expiration Date: June 10, 2017

Estimated time to complete each Module: 60 - 75 minutes

Media: Internet

Back to Top

Faculty:

Richard A. Elion, MD
Associate Professor of Clinical Medicine
George Washington University Medical Center
Washington, DC

Wilbert Jordan, MD
Medical Director
Charles Drew Medical Center
Los Angeles, California  

Helen C. Koenig, MD, MPH
Clinical Assistant Professor of Medicine
Division of Infectious Diseases, Hospital of the University of Pennsylvania
Staff Physician, Jonathan Lax Treatment Center, Philadelphia FIGHT
Philadelphia, Pennsylvania

Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Back to Top 

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Back to Top

Credit Designation:

Module 1 (Detecting HIV: Finding and Testing):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Module 2 (HIV Treatment as Prevention):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Module 3 (Pre-Exposure Prophylaxis):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Module 4 (HIV Prevention for Special Populations):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Back to Top

Disclosure of Conflicts of Interest:

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Richard Elion, MD
  • Consulting Fees: Gilead, ViiV, Merck
  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest or thier Agents (e.g., speakers' bureaus): Gilead, ViiV, Merck
  • Contracted Research: Gilead, ViiV, Merck, Janssen
Wilbert Jordan, MD
  • Contracted Research: Gilead
Helen Koenig, MD, MPH
  • Consulting Fees: Gilead
  • Contracted Research: Gilead
Renslow Sherer, MD
  • Consulting Fees: Gilead, Janssen

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattucci, PharmD, CHCP and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

 

Back to Top

Instructions for Participation and Credit

 

There are no fees for participating and receiving CME credit for this activity. During the period, June 10, 2016 through June 10, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 11573. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

 

Back to Top

Disclosure of Unlabeled Use

 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top

 

 

 

PIM_small

VE logo 300px 

  Jointly provided by the Postgraduate Institute for Medicine and ViralEd, Inc.

This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs 


Prepare to print

Share this page:

Get link code to this page                     


Back to Top